Background Metformin is a commonly used drug in diabetes mellitus treatment. Recently it
has been suggested that the use of metformin on diabetes mellitus patients may lower the …

BACKGROUND: A modest (41%) reduction in abdominal aortic aneurysm (AAA) growth rate
is likely to delay AAA-related events (surgery or rupture) by 5 years, making the notion of …

BACKGROUND: This study aims to investigate the impact of diabetes in the management of
patients with small abdominal aortic aneurysms (AAA). METHODS: Three-hundred sixty …

Insulin resistance accounts for glucotoxicity observed in diabetes and atherosclerotic
disease. Glucotoxicity depends from the shift of glucose metabolism from the glycolytic …

Purpose To test the hypothesis that diabetes-related factors (metabolic syndrome [MetS],
glucose, insulin, and leptin) are inversely associated with abdominal aortic aneurysm (AAA) …

Objective To assess the association of metformin prescription with the risk of aortic
aneurysm, aortic aneurysm events and the enlargement of abdominal aortic aneurysm …

Epidemiological data indicate decreased risk for development and growth of abdominal
aortic aneurysm (AAA) among patients with diabetes mellitus (DM). On the other hand, DM …

Abstract Background Metabolic syndrome (MetS) is a cluster of metabolic abnormalities
strongly associated with risks of cardiovascular diseases. However, a relationship between …

Diabetes mellitus has now reached epidemic proportions in the Western world. The
associated microvascular and macrovascular complications are a result of severe metabolic …

Background. The associations of diabetes and obesity with the risk of abdominal aortic
aneurysm (AAA) are inconclusive in previous studies. Subjects/Methods. We conducted …